Thus, loss of PTCH1 results in constitutive activation of the canonical Hh pathway, as illustrated by loss-of-function mutations found in over 80% of basal cell carcinomas of the skin and in the majority of Shh-type medulloblastomas [3]. The gene discussed is SHH; the disease is medulloblastoma.